Reuters Health News 要約
に引き続いて is a 要約 of 現在の health news 簡潔な／要約するs.
Thailand introduced new 入ること／参加（者） 規則s as 中国 再開するs 国境
Thailand will 要求する international 旅行者s to show proof they are fully vaccinated for COVID before 飛行機で行くing to Thailand, によれば the country's 航空 regulator, as it 準備するs for more tourists after 中国 再開するd its 国境 on Sunday. The Civil 航空 当局 of Thailand (CAAT) said in a 声明 on Saturday that starting 早期に Monday, all foreign arrivals starting 早期に on Monday must 証明する they are vaccinated or 供給する a letter certifying that they have 回復するd from COVID within six months.
中国 says 会談 to 含む Paxlovid in its health 保険 麻薬 名簿（に載せる）／表（にあげる） fail
中国 will not 含む Pfizer Inc's Paxlovid in an update to its 名簿（に載せる）／表（にあげる） of 薬／医学s covered by basic 医療の 保険 計画／陰謀s as the U.S. 会社／堅い 引用するd a high price for the COVID-19 麻薬, 中国's Healthcare 安全 行政 (NHSA) said on Sunday. The COVID-19 antiviral 麻薬 is 現在／一般に covered by the country's 幅の広い healthcare 保険 計画／陰謀 under 一時的な 対策 the regulator introduced in March last year as 突発／発生s rose.
UK PM Sunak to 会合，会う health service leaders as 危機 drags on
総理大臣 Rishi Sunak will on Saturday 会合，会う leaders of England's health service, as it 直面するs one of its toughest ever winters as flu and COVID-19 spread まっただ中に strike 活動／戦闘 by frontline staff who say high インフレーション has eroded their salaries. 救急車s have been 列ing outside hospitals, 直面するing long waits to を引き渡す 患者s to 緊急 区s as doctors and nurses, 妨害するd by 労働者 不足s, struggle to 発射する／解雇する 患者s まっただ中に staff 不足s.
中国 in 会談 with Pfizer for generic COVID 麻薬 - so urces
中国 is in 会談 with Pfizer Inc to 安全な・保証する a license that will 許す 国内の drugmakers to 製造（する） and 分配する a generic 見解／翻訳／版 of the U.S. 会社／堅い's COVID-19 antiviral 麻薬 Paxlovid in 中国, three sources told Reuters. 中国's 医療の 製品s regulator - the 国家の 医療の 製品s 行政 (NMPA) - has been 主要な the 会談 with Pfizer since late last month, one of the sources with knowledge of the 事柄 said.
Factbox-Who can get the newly 認可するd Eisai and Biogen Alzheimer's 麻薬?
The U.S. Food and 麻薬 行政 on Friday 認可するd Eisai Co Ltd and Biogen Inc's Alzheimer's 麻薬 lecanemab for the 治療 of 早期に forms of the 致命的な, brain-wasting 病気. Like their earlier Alzheimer's 麻薬 Aduhelm, lecanemab, to be sold under the brand 指名する Leqembi, belongs to a class of 治療s that 目的（とする） to slow 病気 progression by 除去するing sticky clumps of the 有毒な protein beta amyloid from the brain.
Now able to sell abortion pill, U.S. pharmacies 重さを計る if they should
Pharmacies across the 部隊d 明言する／公表するs are 重さを計るing whether to sell mifepristone, a pill used in 医薬 abortions, に引き続いて the Food and 麻薬 行政's 告示 earlier this week that they can now do so. What they decide is まず第一に／本来 based on where they are 位置を示すd given that almost half the 明言する／公表するs 禁止（する） or 制限する abortion after the 最高裁判所 overturned its 目印 魚の卵 v Wade 判決，裁定, though some pharmacists told Reuters the 地元の culture and 態度s or their own personal beliefs on abortion is what guides them.
中国 再開するs 国境s in final 別れの（言葉，会） to 無-COVID
Travellers streamed into 中国 by 空気／公表する, land and sea on Sunday, many eager for long-を待つd 再会s, as Beijing opened 国境s that have been all but shut since the start of the COVID-19 pandemic. After thre e years, 本土／大陸 中国 opened sea and land crossings with Hong Kong and ended a 必要物／必要条件 for 後継の 旅行者s to 検疫, 取り去る／解体するing a final 中心存在 of a 無-COVID 政策 that had 保護物，者d 中国's 1.4 billion people from the ウイルス but also 削減（する） them off from the 残り／休憩（する） of the world.
Eisai, Biogen get U.S. FDA 是認 for Alzheimer's 麻薬, 適用する for 十分な 是認
The U.S. Food and 麻薬 行政 on Friday 認可するd the Alzheimer's 麻薬 lecanemab developed by Eisai Co Ltd and Biogen Inc for 患者s in the earliest 行う／開催する／段階s of the mind-wasting 病気. Eisai and Biogen said on Saturday the Japanese drugmaker had 適用するd for 十分な FDA 是認 of the 麻薬.
Chinese-made mRNA ワクチン starts 裁判，公判 生産／産物
中国's CanSino Biologics Inc has entered "実験（する） 生産／産物 段階" for its COVID-19 mRNA booster ワクチン, the company said in a 地位，任命する on its social マスコミ account late on Thursday. The ワクチン, known as CS-2034, 的s new Omicron variants of the ウイルス, which are 責任がある the 広大な 大多数 of 感染s that have swept across 中国 since the country began 取り去る／解体するing strict COVID 抑制（する）s last month.
